{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:10:35Z","timestamp":1759407035319,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P2C HD042828"],"award-info":[{"award-number":["P2C HD042828"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI108490","R01-GM125440"],"award-info":[{"award-number":["R01-AI108490","R01-GM125440"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vaccine.2023.08.071","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T09:06:16Z","timestamp":1694682376000},"page":"6461-6469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of HIV virulence in response to disease-modifying vaccines: A modeling study"],"prefix":"10.1016","volume":"41","author":[{"given":"Molly C.","family":"Reid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Mittler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3251-8501","authenticated-orcid":false,"given":"Sarah E.","family":"Stansfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-5763","authenticated-orcid":false,"given":"Steven M.","family":"Goodreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Abernethy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua T.","family":"Herbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.08.071_b0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11904-014-0208-x","article-title":"Epidemiology: a guide for strategies in prevention and care","volume":"11","author":"Vermund","year":"2014","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.vaccine.2023.08.071_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25289","article-title":"The aspirational necessity of HIV prevention","volume":"22","author":"Corey","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.vaccine.2023.08.071_b0015","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1056\/NEJMra066267","article-title":"An HIV vaccine\u2013evolving concepts","volume":"356","author":"Johnston","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.071_b0020","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.4161\/hv.21760","article-title":"HIV vaccines: can CD4+ T cells be of help?","volume":"8","author":"Van Braeckel","year":"2012","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2023.08.071_b0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1086\/510909","article-title":"Estimating the benefit of an HIV-1 vaccine that reduces viral load set point","volume":"195","author":"Gupta","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.071_b0030","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe5938","article-title":"Understanding COVID-19 vaccine efficacy","author":"Lipsitch","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.08.071_b0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.071_b0040","doi-asserted-by":"crossref","unstructured":"Grannis SJ, Rowley EA, Ong TC, Stenehjem E, Klein NP, DeSilva MB, et al. Interim estimates of COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August 2021. MMWR Morb Mortal Wkly Rep 2021;70:1291\u20133. https:\/\/doi.org\/10.15585\/mmwr.mm7037e2.","DOI":"10.15585\/mmwr.mm7037e2"},{"key":"10.1016\/j.vaccine.2023.08.071_b0045","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.071_b0050","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2023.08.071_b0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2010.00974.x","article-title":"Influenza vaccine immunology","volume":"239","author":"Dormitzer","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2023.08.071_b0060","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.08.071_b0065","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1128\/JVI.00171-06","article-title":"Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239","volume":"80","author":"Wilson","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0070","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1126\/science.1124226","article-title":"Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys","volume":"312","author":"Letvin","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.08.071_b0075","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1128\/JVI.73.10.8201-8215.1999","article-title":"Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques","volume":"73","author":"Polacino","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0080","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0264-410X(02)00076-2","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"20","author":"Amara","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.071_b0085","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.20060657","article-title":"Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge","volume":"203","author":"Mattapallil","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2023.08.071_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002185","article-title":"Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach","volume":"7","author":"Shirreff","year":"2011","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/v3030204","article-title":"A strong case for viral genetic factors in HIV virulence","volume":"3","author":"M\u00fcller","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.08.071_b0100","doi-asserted-by":"crossref","unstructured":"Miller IF, Metcalf CJE. Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2. R Soc Open Sci n.d.;9:211021. https:\/\/doi.org\/10.1098\/rsos.211021.","DOI":"10.1098\/rsos.211021"},{"key":"10.1016\/j.vaccine.2023.08.071_b0105","doi-asserted-by":"crossref","first-page":"e1003973","DOI":"10.1371\/journal.pcbi.1003973","article-title":"Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial","volume":"11","author":"Edlefsen","year":"2015","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"Rolland","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.08.071_b0115","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1086\/655653","article-title":"Viral evolution and escape during acute HIV-1 infection","volume":"202","author":"Boutwell","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.071_b0120","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1128\/JVI.79.21.13239-13249.2005","article-title":"Selective escape from CD8+ T-Cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution","volume":"79","author":"Allen","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0125","doi-asserted-by":"crossref","first-page":"e15639","DOI":"10.1371\/journal.pone.0015639","article-title":"Dynamics of viral evolution and CTL responses in HIV-1 infection","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.071_b0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.vaccine.2017.12.004","article-title":"HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine","volume":"36","author":"Herbeck","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.071_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vew028","article-title":"Evolution of HIV virulence in response to widespread scale up of antiretroviral therapy: a modeling study","volume":"2","author":"Herbeck","year":"2016","journal-title":"Virus Evol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0140","article-title":"Sexual role and HIV-1 set point viral load among men who have sex with men","author":"Stansfield","year":"2018","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2023.08.071_b0145","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vey032","article-title":"Relational concurrency, stages of infection, and the evolution of HIV set point viral load","volume":"4","author":"Goodreau","year":"2018","journal-title":"Virus Evol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.18637\/jss.v084.i08","article-title":"EpiModel: an r package for mathematical modeling of infectious disease over networks","volume":"84","author":"Jenness","year":"2018","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2023.08.071_b0155","doi-asserted-by":"crossref","first-page":"17441","DOI":"10.1073\/pnas.0708559104","article-title":"Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis","volume":"104","author":"Fraser","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2023.08.071_b0160","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veab011","article-title":"Test-and-treat coverage and HIV virulence evolution among men who have sex with men","volume":"7","author":"Stansfield","year":"2021","journal-title":"Virus Evol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0165","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1056\/NEJMoa1508952","article-title":"Prospective study of acute HIV-1 infection in adults in East Africa and Thailand","volume":"374","author":"Robb","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.071_b0170","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1097\/QAD.0000000000000854","article-title":"CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time","volume":"29","author":"Cori","year":"2015","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.vaccine.2023.08.071_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001525","article-title":"Lack of evidence for changing virulence of HIV-1 in North America","volume":"3","author":"Herbeck","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.071_b0180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/jir747","article-title":"Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples","volume":"205","author":"Hughes","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.071_b0185","doi-asserted-by":"crossref","unstructured":"Rosenberg ES, Grey JA, Sanchez TH, Sullivan PS. Rates of Prevalent HIV Infection, Prevalent Diagnoses, and New Diagnoses Among Men Who Have Sex With Men in US States, Metropolitan Statistical Areas, and Counties, 2012-2013. JMIR Public Health Surveill 2016;2. https:\/\/doi.org\/10.2196\/publichealth.5684.","DOI":"10.2196\/publichealth.5684"},{"key":"10.1016\/j.vaccine.2023.08.071_b0190","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1098\/rspb.2003.2370","article-title":"Imperfect vaccination: some epidemiological and evolutionary consequences","volume":"270","author":"Gandon","year":"2003","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2023.08.071_b0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/414751a","article-title":"Imperfect vaccines and the evolution of pathogen virulence","volume":"414","author":"Gandon","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.08.071_b0200","doi-asserted-by":"crossref","unstructured":"Smith RJ. Could Low-Efficacy Malaria Vaccines Increase Secondary Infections in Endemic Areas? In: Deutsch A, Parra RB de la, Boer RJ de, Diekmann O, Jagers P, Kisdi E, et al., editors. Math. Model. Biol. Syst. Vol. II Epidemiol. Evol. Ecol. Neural Syst. Brain Innov. Math. Methods, Boston, MA: Birkh\u00e4user; 2008, p. 3\u20139. https:\/\/doi.org\/10.1007\/978-0-8176-4556-4_1.","DOI":"10.1007\/978-0-8176-4556-4_1"},{"key":"10.1016\/j.vaccine.2023.08.071_b0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1568005054201616","article-title":"Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: the problem of subtypes","volume":"5","author":"Blower","year":"2005","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1016\/j.vaccine.2023.08.071_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4fd10061-5a1e-4164-833e-34943a74301c","article-title":"Modeling HIV Vaccines in Brazil: Assessing the Impact of a Future HIV Vaccine on Reducing New Infections, Mortality and Number of People Receiving ARV","volume":"5","author":"Fonseca","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.071_b0215","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1473-3099(04)01148-X","article-title":"Could disease-modifying HIV vaccines cause population-level perversity?","volume":"4","author":"Smith","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.071_b0220","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1128\/JVI.78.20.11340-11351.2004","article-title":"Predicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency Virus","volume":"78","author":"Davenport","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.071_b0225","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/QAD.0000000000003343","article-title":"Correlations between community-level HIV preexposure prophylaxis coverage and individual-level sexual behaviors among United States MSM","volume":"36","author":"Mann","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2023.08.071_b0230","doi-asserted-by":"crossref","first-page":"e25470","DOI":"10.1002\/jia2.25470","article-title":"Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90\u201390-90 in sub-Saharan Africa \u2013 a systematic review and meta-analysis","volume":"23","author":"Green","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.vaccine.2023.08.071_b0235","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk: a systematic review","volume":"28","author":"Patel","year":"2014","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.vaccine.2023.08.071_b0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1874613601610010034","article-title":"HIV infection and AIDS in Sub-Saharan Africa: current status","volume":"10","author":"Kharsany","year":"2016","journal-title":"Challenges Opportunities Open AIDS J"},{"key":"10.1016\/j.vaccine.2023.08.071_b0245","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.abk1688","article-title":"A highly virulent variant of HIV-1 circulating in the Netherlands","volume":"375","author":"Wymant","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.08.071_b0250","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1038\/s41598-021-85487-w","article-title":"Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study","volume":"11","author":"Peebles","year":"2021","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:30:14Z","timestamp":1759404614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23010277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0264410X23010277"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of HIV virulence in response to disease-modifying vaccines: A modeling study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}